EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous 
Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2021 
08-Apr-2021 / 19:15 CET/CEST 
Release of an ad hoc announcement pursuant to Art. 53 KR 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Reinach, April 8, 2021 - Evolva shareholders approved all proposals put forward by the Board of Directors at Evolva's 
Annual General Meeting (AGM). In accordance with the Swiss COVID-19 Ordinance 3, the 2021 AGM was held without 
shareholders being physically present. Accordingly, shareholders exercised their shareholder rights via the Independent 
Proxy. 
Increase of the Authorized Capital 
Shareholders approved the increase of Authorized Capital in the maximum amount of CHF 2,968,782.35 (respectively 
maximum of 59,375,647 registered shares) by CHF 4,634,391.20 to the new maximum amount of CHF 7,603,173.55 
(respectively maximum of 152,063,471 registered shares). 
Elections of the Chairman and of the Board of Directors 
Shareholders re-elected Beat In-Albon as Chairman of the Board of Directors as well as Richard Ridinger and Stephan 
Schindler as members of the Board of Directors, for a one year period. 
In addition, Christoph Breucker was elected as new member of the Board of Directors. 
Election of the Compensation Committee 
Shareholders elected Richard Ridinger, Stephan Schindler and Christoph Breucker as members of the Compensation 
Committee. 
Election of the Auditors 
The Shareholders elected Mazars Ltd., Zurich, as auditors for a term of one year. 
For a detailed listing of all resolutions at the 2021 Annual General Meeting, please visit: evolva.com/shareholder-info 
/annual-general-meeting-of-shareholders/. 
About Evolva 
Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on 
nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva's 
employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing 
and sensory enjoyment. Find out more at evolva.com. 
For Evolva multi media content, please visit: evolva.com/multimedia-library/. 
Disclaimer 
This press release contains specific forward-looking statements, e.g. statements including terms like believe assume, 
expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties 
and other factors which may result in a substantial divergence between the actual results, financial situation, 
development or performance of the company and those explicity or implicity presumed in these statements. The company 
assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. 
Contact 
Barbara Duci 
Head of Investor and Corporate Relations 
+41 61 485 2003 
+41 79 739 2636 
barbarad@evolva.com 
=---------------------------------------------------------------------------------------------------------------------- 
End of ad hoc announcement 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Evolva Holding SA 
              Duggingerstrasse 23 
              4153 Reinach 
              Switzerland 
Phone:        +41 61 485 20 00 
Internet:     www.evolva.com 
ISIN:         CH0021218067 
Valor:        2121806 
Listed:       SIX Swiss Exchange 
EQS News ID:  1182654 
 
End of Announcement EQS Group News Service 
=------------

1182654 08-Apr-2021 CET/CEST

(END) Dow Jones Newswires

April 08, 2021 13:17 ET (17:17 GMT)